好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Cross-sectional Retrospective Study of Perioperative Seizure Risk and Antiseizure Medication Prescribing Practices for Children with Supratentorial Tumors with and Without History of Preoperative Seizures
Epilepsy/Clinical Neurophysiology (EEG)
P9 - Poster Session 9 (5:00 PM-6:00 PM)
11-011

We studied perioperative seizures in children with supratentorial tumors with and without preoperative seizures and antiseizure medication (ASM) prescribing practices.

ASMs are prescribed to patients with supratentorial tumors with side effects.  Levetiracetam has few interactions but causes neuropsychiatric side effects.  Weaning ASMs is nonstandard following craniotomy with resection of supratentorial tumors.  Postoperative seizures have previously been infrequent in retrospective cohorts of children and adults and randomized controlled trials in adults after tumor treatment.  We hypothesize rates of postoperative seizures in children with supratentorial tumors without preoperative seizures are low.

We retrospectively studied 341 consecutive children from 2020-2024 with CNS tumors.  Cases with infratentorial tumors and without craniotomy were excluded.  Demographics, tumor type, location, ASMs prescribed/weaned, gross total/partial resection, preoperative/postoperative seizures, and epilepsy at >2 years were assessed (n=140).  

Preoperative seizures predicted postoperative seizures with trend toward significance (13.5%vs5.8%,χ2=3.01,p=0.08).  Tumor location (Temporal,Frontal,Parietal,Occipital,Insular,Multilobar) did not predict postoperative seizures (χ2=2.54,p=0.64).  ASMs were prescribed more often in children with preoperative seizures (97%vs67%,χ2=12.74,p=0.00035).  For children with preoperative seizures, neurologists prescribed ASMs most often (76.4%vs23.5%,χ2=9.52,p=0.002).  Neurosurgeons prescribed ASMs most often for children without preoperative seizures (90.3%vs9.7%,χ2=46.7,p=8.1x10-12). Gross total versus partial resection did not predict postoperative seizures (7.8%vs7.8%,χ2=0.00032,p=0.98).  Interestingly, for 106 children with >2 year follow up, starting ASMs was associated with epilepsy (46%vs10%,χ2=12.00,p=0.0005).  For 23 children with >2 year follow up and preoperative seizures, gross total versus partial resection did not predict development of epilepsy (50%vs66%,χ2=0.61,p=0.43).  For 83 children with >2 year follow up without preoperative seizures, gross total versus partial resection did not predict development of epilepsy (25%vs31%,χ2=0.37,p=0.53).  Weaning of ASMs was nonstandard with 7 days postoperatively versus other methods (40%vs60%,χ2=1.2,p=0.27).

Postoperative seizures are rare in children with supratentorial tumors with and without preoperative seizures.  ASMs are prescribed more often following preoperative seizures with nonstandard ASM weaning practices.  Prospective study is necessary to standardize practice.

Authors/Disclosures
Ashli Elrod, MD (IU Department of Neurology)
PRESENTER
Dr. Elrod has nothing to disclose.
Minao Tang Mr. Tang has nothing to disclose.
Mariah Shirrell, CRC Mrs. Shirrell has nothing to disclose.
Andrea Knight, MD, MSCE The institution of Dr. Knight has received research support from Lupus Research Alliance. The institution of Dr. Knight has received research support from Cure JM Foundation. The institution of Dr. Knight has received research support from Lupus Foundation of America. The institution of Dr. Knight has received research support from US Department of Defense. The institution of Dr. Knight has received research support from US Center for Disease Control. The institution of Dr. Knight has received research support from Childhood Arthritis & Rheumatology Research Alliance. The institution of Dr. Knight has received research support from Cassie and Friends Society. The institution of Dr. Knight has received research support from Brain Canada. The institution of Dr. Knight has received research support from Canada Institutes of Health Research. Dr. Knight has received publishing royalties from a publication relating to health care. Dr. Knight has received personal compensation in the range of $500-$4,999 for serving as a Member of Scientific Advisory Board with Lupus Research Alliance.
Scott Coven, DO Dr. Coven has nothing to disclose.
Jignesh Tailor, MD, PhD The institution of Dr. Tailor has received research support from NIH. Dr. Tailor has received intellectual property interests from a discovery or technology relating to health care.
Derryl Miller, MD (Riley Child Neurology and Indiana University Health Physicians) Dr. Miller has nothing to disclose.